New Delhi, Feb. 4 -- Brokerage firm Nuvama has shared its top stock picks following the Q3FY25 earnings season, highlighting companies that have delivered strong performances or hold promising growth potential.

Divi's Laboratories: Nuvama noted that Divi's Laboratories outperformed consensus estimates across key financial metrics, with revenue, EBITDA, and PAT surpassing expectations by 3 percent, 8 percent, and 18 percent, respectively. The company posted a robust EBITDA margin of 32 percent, exceeding consensus by 144 basis points. Even after adjusting for a lower tax rate, PAT remained 7 percent ahead of estimates. Divi's is actively expanding its product portfolio and client base, with GLP-1 emerging as a key growth driver. Nuvama re...